Regulation of the immune and inflammatory responses by the 'atypical' chemokine receptor D6

Journal of Pathology

Volumn 229, Issue 2, 2013, Pages 168-175

  Graham, Gerard J ^a   Locati, Massimo ^b,c  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF MILAN   (Italy)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

chemokine; decoy receptor; immunity; inflammation

Indexed keywords

BETA CHEMOKINE; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7; CHEMOKINE RECEPTOR D6; UNCLASSIFIED DRUG;

BIOCHEMISTRY; BIOLOGY; CELL MIGRATION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; INTESTINE; LUNG; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REPRODUCTION; REVIEW; SKIN;

ANIMALS; CHEMOKINES, CC; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; PROTEIN CONFORMATION; RECEPTORS, CCR10; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84871095961     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4123     Document Type: Review

References (79)

1. Rot A, von Andrian UH,. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol 2004; 22: 891-928. (Pubitemid 38680444)
2. Zlotnik A, Yoshie O,. Chemokines: a new classification system and their role in immunity. Immunity 2000; 12: 121-127. (Pubitemid 30398626)
3. Nomiyama H, Osada N, Yoshie O,. A family tree of vertebrate chemokine receptors for a unified nomenclature. Developmental Comp Immunol 2011; 35: 705-715.
4. Zlotnik A, Yoshie O, Nomiyama H,. The chemokine and chemokine receptor superfamilies and their molecular evolution. Genome Biology 2006; 7: 243.
5. Murphy PM, Baggiolini M, Charo IF, et al,. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 2000; 52: 145-176. (Pubitemid 30127598)
6. Mantovani A,. The chemokine system: redundancy for robust outputs. Immunol Today 1999; 20: 254-257. (Pubitemid 29258161)
7. Forster R, Davalos-Misslitz AC, Rot A,. CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol 2008; 8: 362-371. (Pubitemid 351595218)
8. Parsonage G, Filer AD, Haworth O, et al,. A stromal address code defined by fibroblasts. Trends Immunol 2005; 26: 150-156. (Pubitemid 40312522)
9. + gut intraepithelial lymphocytes. Blood 2001; 98: 2626-2632.
10. Homey B, Alenius H, Muller A, et al,. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med 2002; 8: 157-165. (Pubitemid 34155127)
11. Ohl L, Henning G, Krautwald S, et al,. Cooperating mechanisms of CXCR5 and CCR7 in development and organization of secondary lymphoid organs. J Exp Med 2003; 197: 1199-1204. (Pubitemid 36570075)
12. Horuk R. Opinion,. Chemokine receptor antagonists: overcoming developmental hurdles. Nat Rev Drug Discov 2009; 8: 23-33.
13. Schall TJ, Proudfoot AEI,. Overcoming hurdles in developing successful drugs targeting chemokine receptors. Nat Rev Immunol 2011; 11: 355-363.
14. Graham GJ,. D6 and the atypical chemokine receptor family: novel regulators of immune and inflammatory processes. Eur J Immunol 2009; 39: 342-351.
15. Mantovani A, Bonecchi R, Locati M,. Tuning inflammation and immunity by chemokine sequestration: decoys and more. Nat Rev Immunol 2006; 6: 907-918. (Pubitemid 44851733)
16. Fredriksson R, Lagerström MC, Lundin LG, et al,. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol 2003; 63: 1256-1272. (Pubitemid 36627220)
17. Heinzel K, Benz C, Bleul CC,. A silent chemokine receptor regulates steady-state leukocyte homing in vivo. Proc Natl Acad Sci USA 2007; 104: 8421-8426. (Pubitemid 47175503)
18. Comerford I, Milasta S, Morrow V, et al,. The chemokine receptor CCX-CKR mediates effective scavenging of CCL19 in vitro. Eur J Immunol 2006; 36: 1904-1916. (Pubitemid 44089056)
19. Comerford I, Nibbs RJ, Litchfield W, et al,. The atypical chemokine receptor CCX-CKR scavenges homeostatic chemokines in circulation and tissues and suppresses Th17 responses. Blood 116: 4130-4140.
20. Sierro F, Biben C, Martinez-Munoz L, et al,. Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7. Proc Natl Acad Sci USA 2007; 104: 14759-14764. (Pubitemid 350003216)
21. Valentin G, Haas P, Gilmour D,. The chemokine SDF1a coordinates tissue migration through the spatially restricted activation of Cxcr7 and Cxcr4b. Curr Biol 2007; 17: 1026-1031. (Pubitemid 46899533)
22. Yu S, Crawford D, Tsuchihashi T, et al,. The chemokine receptor CXCR7 functions to regulate cardiac valve remodeling. Dev Dynam 2011; 240: 384-393.
23. Doitsidou M, Reichman-Fried M, Stebler J, et al,. Guidance of primordial germ cell migration by the chemokine SDF-1. Cell 2002; 111: 647-659. (Pubitemid 35441247)
24. Leick M, Catusse J, Follo M, et al,. CCL19 is a specific ligand of the constitutively recycling atypical human chemokine receptor CRAM-B. Immunology 2010; 129: 536-546.
25. Gardner L, Patterson AM, Ashton BA, et al,. The human Duffy antigen binds selected inflammatory but not homeostatic chemokines. Biochem Biophys Res Commun 2004; 321: 306-312. (Pubitemid 39055746)
26. Dawson TC, Lentsch AB, Wang Z, et al,. Exaggerated response to endotoxin in mice lacking the Duffy antigen/receptor for chemokines (DARC). Blood 2000; 96: 1681-1684. (Pubitemid 30661047)
27. Middleton J, Neil S, Wintle J, et al,. Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell 1997; 91: 385-395. (Pubitemid 27467969)
28. Pruenster M, Mudde L, Bombosi P, et al,. The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity. Nat Immunol 2009; 10: 101-108.
29. Nibbs RJ, Wylie SM, Pragnell IB, et al,. Cloning and characterization of a novel murine β-chemokine receptor, D6. Comparison to three other related macrophage inflammatory protein-1α receptors, CCR-1, CCR-3, and CCR-5. J Biol Chem 1997; 272: 12495-12504. (Pubitemid 27203340)
30. Nibbs RJ, Wylie SM, Yang J, et al,. Cloning and characterization of a novel promiscuous human β-chemokine receptor, D6. J Biol Chem 1997; 272: 32078-32083. (Pubitemid 28011878)
31. Bonini JA, Martin SK, Dralyuk F, et al,. Cloning, expression, and chromosomal mapping of a novel human CC-chemokine receptor (CCR10) that displays high-affinity binding for MCP-1 and MCP-3. DNA Cell Biol 1997; 16: 1249-1256. (Pubitemid 27479393)
32. Bonecchi R, Locati M, Galliera E, et al,. Differential recognition and scavenging of native and truncated macrophage-derived chemokine (macrophage-derived chemokine/CC chemokine ligand 22) by the D6 decoy receptor. J Immunol 2004; 172: 4972-4976. (Pubitemid 38456423)
33. Fra AM, Locati M, Otero K, et al,. Cutting edge: scavenging of inflammatory CC chemokines by the promiscuous putatively silent chemokine receptor D6. J Immunol 2003; 170: 2279-2282. (Pubitemid 36245612)
34. Savino B, Borroni EM, Torres NM, et al,. Recognition versus adaptive up-regulation and degradation of CC chemokines by the chemokine decoy receptor D6 are determined by their N-terminal sequence. J Biol Chem 2009; 284: 26207-26215.
35. Nibbs RJ, Yang J, Landau NR, et al,. LD78β, a non-allelic variant of human MIP-1α (LD78α), has enhanced receptor interactions and potent HIV suppressive activity. J Biol Chem 1999; 274: 17478-17483.
36. Menten P, Struyf S, Schutyser E, et al,. The LD78β isoform of MIP-1α is the most potent CCR5 agonist and HIV-1-inhibiting chemokine. J Clin Invest 1999; 104: R1-5. (Pubitemid 29534336)
37. Proost P, Menten P, Struyf S, et al,. Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78β into a most efficient monocyte attractant and CCR1 agonist. Blood 2000; 96: 1674-1680. (Pubitemid 30662110)
38. Nibbs RJ, Kriehuber E, Ponath PD, et al,. The β-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors. Am J Pathol 2001; 158: 867-877. (Pubitemid 32221780)
39. Madigan J, Freeman DJ, Menzies F, et al,. Chemokine scavenger D6 is expressed by trophoblasts and aids the survival of mouse embryos transferred into allogeneic recipients. J Immunol 2010; 184: 3202-3212.
40. Martinez de la Torre Y, Buracchi C, Borroni EM, et al,. Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6. Proc Natl Acad Sci USA 2007; 104: 2319-2324. (Pubitemid 46391395)
41. Hansell CAH, Schiering C, Kinstrie R, et al,. Universal expression and dual function of the atypical chemokine receptor D6 on innate-like B cells in mice. Blood 2011; 117: 5413-5424.
42. McKimmie CS, Fraser AR, Hansell C, et al,. Hemopoietic cell expression of the chemokine decoy receptor D6 is dynamic and regulated by GATA1. J Immunol 2008; 181: 3353-3363.
43. Singh MD, King V, Baldwin H, et al,. Elevated expression of the chemokine-scavenging receptor D6 is associated with impaired lesion development in psoriasis. Am J Pathol 2012; 181: 1158-1164.
44. Blackburn PE, Simpson CV, Nibbs RJ, et al,. Purification and biochemical characterization of the D6 chemokine receptor. Biochem J 2004; 379: 263-272. (Pubitemid 38570098)
45. Farzan M, Mirzabekov T, Kolchinsky P, et al,. Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry. Cell 1999; 96: 667-676. (Pubitemid 29122809)
46. Seibert C, Cadene M, Sanfiz A, et al,. Tyrosine sulfation of CCR5 N-terminal peptide by tyrosylprotein sulfotransferases 1 and 2 follows a discrete pattern and temporal sequence. Proc Natl Acad Sci USA 2002; 99: 11031-11036. (Pubitemid 34920874)
47. Nibbs RJ, McLean P, McCulloch C, et al,. Structure-function dissection of D6, an atypical scavenger receptor. Methods Enzymol 2009; 460: 245-261.
48. Weber M, Blair E, Simpson CV, et al,. The chemokine receptor D6 constitutively traffics to and from the cell surface to internalize and degrade chemokines. Mol Biol Cell 2004; 15: 2492-2508. (Pubitemid 38580663)
49. Bonecchi R, Borroni EM, Anselmo A, et al,. Regulation of D6 chemokine scavenging activity by ligand- and Rab11-dependent surface up-regulation. Blood 2008; 112: 493-503.
50. Borroni EM, Buracchi C, Savino B, et al,. Role of the chemokine scavenger receptor D6 in balancing inflammation and immune activation. Method Enzymol 2009; 460: 231-243.
51. Borroni EM, Bonecchi R, Mantovani A, et al,. Chemoattractant receptors and leukocyte recruitment: more than cell migration. Sci Signal 2009; 2: pe10.
52. Shenoy SK, Lefkowitz RJ,. Multifaceted roles of β-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling. Biochem J 2003; 375: 503-515. (Pubitemid 37433499)
53. McCulloch CV, Morrow V, Milasta S, et al,. Multiple roles for the carboxy-terminal tail of the chemokine scavenger D6. J Biol Chem 2008; 283: 7972-7982.
54. Galliera E, Jala VR, Trent JO, et al,. β-Arrestin-dependent constitutive internalization of the human chemokine decoy receptor D6. J Biol Chem 2004; 279: 25590-25597. (Pubitemid 38756820)
55. Ferguson SSG,. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev 2001; 53: 1-24. (Pubitemid 32173106)
56. Shenoy SK, Lefkowitz RJ., β-Arrestin-mediated receptor trafficking and signal transduction. TIBS 2011; 32: 521-533.
57. Lagane B, Ballet S, Planchenault T, et al,. Mutation of the DRY motif reveals different structural requirements for the CC chemokine receptor 5-mediated signaling and receptor endocytosis. Mol Pharmacol 2005; 67: 1966-1976. (Pubitemid 41007778)
58. Jamieson T, Cook DN, Nibbs RJ, et al,. The chemokine receptor D6 limits the inflammatory response in vivo. Nat Immunol 2005; 6: 403-411. (Pubitemid 41716781)
59. Martinez de la Torre Y, Locati M, Buracchi C, et al,. Increased inflammation in mice deficient for the chemokine decoy receptor D6. Eur J Immunol 2005; 35: 1342-1346. (Pubitemid 40691415)
60. Mantovani A, Allavena P, Sica A, et al,. Cancer-related inflammation. Nature 2008; 454: 436-444.
61. Nibbs RJ, Gilchrist DS, King V, et al,. The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors. J Clin Invest 2007; 117: 1884-1892. (Pubitemid 47036322)
62. Wu FY, Ou ZL, Feng LY, et al,. Chemokine decoy receptor d6 plays a negative role in human breast cancer. Mol Cancer Res 2008; 6: 1276-1288.
63. Zeng XH, Ou ZL, Yu KD, et al,. Coexpression of atypical chemokine binders (ACBs) in breast cancer predicts better outcomes. Breast Cancer Res Treat 2011; 125: 715-727.
64. Codullo V, Baldwin HM, Singh MD, et al,. An investigation of the inflammatory cytokine and chemokine network in systemic sclerosis. Annals Rheumat Dis 2011; 70: 1115-1121.
65. Nickoloff BJ, Qin JZ, Nestle FO,. Immunopathogenesis of psoriasis. Clin Rev Allergy Immunol 2007; 33: 45-56. (Pubitemid 351514147)
66. Vetrano S, Borroni EM, Sarukhan A, et al,. The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6. Gut 2010; 59: 197-206.
67. Bordon Y, Hansell CA, Sester DP, et al,. The atypical chemokine receptor D6 contributes to the development of experimental colitis. J Immunol 2009; 182: 5032-5040.
68. Whitehead GS, Wang T, DeGraff LM, et al,. The chemokine receptor D6 has opposing effects on allergic inflammation and airway reactivity. Am J Respir Crit Care Med 2007; 175: 243-249. (Pubitemid 46203127)
69. Di Liberto D, Locati M, Caccamo N, et al,. Role of the chemokine decoy receptor D6 in balancing inflammation, immune activation, and antimicrobial resistance in Mycobacterium tuberculosis infection. J Exp Med 2008; 205: 2075-2084.
70. Bazzan E, Saetta M, Turato G, et al,. Expression of the atypical chemokine receptor D6 in human alveolar macrophages in chronic obstructive pulmonary disease. Chest 2012. [Epub ahead of print doi:10.1378/chest.11-3220]
71. Wiederholt T, von Westernhagen M, Zaldivar MM, et al,. Genetic variations of the chemokine scavenger receptor D6 are associated with liver inflammation in chronic hepatitis C. Human Immunol 2008; 69: 861-866.
72. Berres M-L, Trautwein C, Zaldivar MM, et al,. The chemokine scavenging receptor D6 limits acute toxic liver injury in vivo. Biol Chem 2009; 390: 1039-1045.
73. Cochain C, Auvynet C, Poupel L, et al,. The chemokine decoy receptor D6 prevents excessive inflammation and adverse ventricular remodeling after myocardial infarction. Arterioscler Thromb Vasc Biol 2012; 32: 2206-2213.
74. Liu L, Graham GJ, Damodaran A, et al,. Cutting edge: the silent chemokine receptor D6 is required for generating T cell responses that mediate experimental autoimmune encephalomyelitis. J Immunol 2006; 177: 17-21. (Pubitemid 43939108)
75. Graham GJ, McKimmie CS,. Chemokine scavenging by D6: a movable feast? Trends Immunol 2006; 27: 381-386. (Pubitemid 44038664)
76. Lee KM, McKimmie CS, Gilchrist DS, et al,. D6 facilitates cellular migration and fluid flow to lymph nodes by suppressing lymphatic congestion. Blood 2011; 118: 6220-6229.
77. hi monocyte traffic and immunosuppressive activities by atypical chemokine receptor D6. Blood 2012; 119: 5250-5260.
78. Bradford L, Marshall H, Robertson H, et al,. Cardiac allograft rejection: examination of the expression and function of the decoy chemokine receptor D6. Transplantation 89: 1411-1416.
79. Cardona AE, Sasse ME, Liu L, et al,. Scavenging roles of chemokine receptors: chemokine receptor deficiency is associated with increased levels of ligand in circulation and tissues. Blood 2008; 112: 256-263.